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To understand circumstances of tuberculosis trans-
mission that strain public health resources, we systematically 
reviewed Centers for Disease Control and Prevention 
(CDC) staff reports of US outbreaks in which CDC 
participated during 2002–2008 that involved >3 culture-
conﬁ   rmed tuberculosis cases linked by genotype and 
epidemiology. Twenty-seven outbreaks, representing 398 
patients, were reviewed. Twenty-four of the 27 outbreaks 
involved primarily US-born patients; substance abuse 
was another predominant feature of outbreaks. Prolonged 
infectiousness because of provider- and patient-related 
factors was common. In 17 outbreaks, a drug house was a 
notable contributing factor. The most frequently documented 
intervention to control the outbreak was prioritizing contacts 
according to risk for infection and disease progression 
to ensure that the highest risk contacts were completely 
evaluated. US-born persons with reported substance abuse 
most strongly characterized the tuberculosis outbreaks in 
this review. Substance abuse remains one of the greatest 
challenges to controlling tuberculosis transmission in the 
United States.
A
mong the major challenges in achieving tuberculosis 
(TB) elimination in the United States are preventing, 
detecting, and responding to TB outbreaks. Identifying 
high-risk settings and applying effective control measures to 
reduce TB transmission are basic principles of TB control. 
Since the 1985–1992 TB resurgence in the United States, 
enhanced infection control measures in health care facilities 
have successfully reduced nosocomial transmission and 
outbreaks (1). However, outbreaks in community settings 
have continued to occur, calling for increased vigilance in 
understanding and controlling TB transmission (1).
When health departments determine that they have 
exceeded their surge capacity to control a TB outbreak, 
the Centers for Disease Control and Prevention (CDC) 
Division of Tuberculosis Elimination may be invited to 
assist. During an onsite investigation lasting ≈2–3 weeks, 
CDC works closely with its public health partners to 
describe the epidemiology of the outbreak, ﬁ  nd additional 
cases, identify transmission sites, prioritize contacts 
for screening, and implement control measures (2). 
To understand circumstances of TB transmission that 
tax local resources, we present an overview of US TB 
outbreaks during 2002–2008 for which CDC assisted in 
the investigation. We identiﬁ  ed the outbreak population, 
outbreak contributing factors, the most common 
transmission sites, and interventions used to control these 
challenging outbreaks.
Methods
Inclusion Criteria and Data Sources
We conducted a retrospective review of TB outbreak 
investigations in the United States for which CDC 
provided onsite assistance during 2002–2008. Included in 
the review were outbreaks having documented evidence 
of  Mycobacterium tuberculosis transmission with >3 
culture-conﬁ   rmed TB cases linked by both genotype 
and epidemiology. Genotyping methods included 
spoligotyping (all years) and either restriction fragment 
length polymorphism (2002) or 12-locus mycobacterial 
interspersed repetitive units (MIRU) (2003–2008). Linkage 
by epidemiology meant known exposure to another 
outbreak patient by sharing enclosed airspace in the same 
period. Linkage by genotype required matching results by 
whichever genotyping methods were used for that outbreak 
(generally by spoligotype and either restriction fragment 
length polymorphism or 12-locus MIRU). 
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We systematically abstracted data on case 
characteristics, outbreak contributing factors, transmission 
sites, and interventions (including contact investigation) 
from reports written by CDC teams upon return from 
outbreak investigations. All reports were uniformly 
written (with background, methods, results, discussion, 
and conclusion sections) and included aggregate data on 
demographic, clinical, and social risk factors of cases, 
epidemiologic linkages, genotyping results, and contact 
investigations. These data covered the period of the 
onsite investigation and were either provided by the 
health departments or collected by CDC as part of the 
investigation. The reports also discussed the cause of the 
outbreak and were sent back to the respective local and 
state health departments with recommendations to further 
assist in achieving control of the outbreak. We referred to 
any subsequent presentations and publications describing 
the investigation (3–19) to check data quality and accuracy 
of outbreak contributing factors and transmission sites. For 
any discrepancy in number of outbreak cases, we deferred 
to the CDC reports to ensure consistency in the period of 
data collection across all outbreaks included in the review.
Deﬁ  nitions
We deﬁ  ned outbreaks based on CDC guidelines for 
contact investigation as detection of TB disease among 
>2 persons exposed to a person with infectious TB (20), 
i.e., >3 linked cases within 2 years. The standard National 
TB Surveillance System variables were abstracted for 
all patients (21). Demographic, medical, and social 
characteristics were ascribed to an outbreak if >50% of 
the patients involved in the outbreak had that particular 
characteristic. For outbreak contributing factors, hotspots, 
and interventions, discrete categories were created based 
on recurring themes in the reports to enable systematic 
abstraction and quantiﬁ  cation of these variables. Because 
multiple outbreak contributing factors and a large number 
of interventions were documented in CDC reports for 
each outbreak, we abstracted 2 factors considered by the 
onsite investigators to be key to fueling the outbreak and 3 
interventions not already being used that were either used 
by the CDC team onsite or recommended to be pivotal to 
the overall control effort. The frequency that each category 
was encountered was totaled to quantify these outbreak 
variables. Whenever feasible, a member of the original 
team investigating the outbreak was consulted to review 
the accuracy of abstracted data.
Prolonged infectious period was deﬁ  ned as >3 months 
between symptom onset and the date that effective treatment 
had been administered for 2 weeks (20). Delayed diagnosis 
was deﬁ  ned as >2 months between symptom onset and 
date that the patient ﬁ  rst sought care for TB symptoms or 
that TB treatment was initiated (22,23). Incomplete contact 
investigations meant inability to either locate or complete 
evaluation of contacts because of limited resources or 
a hard-to-reach population. Hotspots were deﬁ  ned  as 
transmission sites where >2 outbreak patients had spent 
substantial time together, as determined by local public 
health investigators. Drug house was deﬁ  ned as a venue 
characterized by the sale or use of illicit drugs. Household 
was deﬁ  ned as a residential location without documented 
illicit drug use.
Results
Of the 51 TB investigations in which CDC participated 
during 2002–2008, a total of 27 met the inclusion criteria. 
Twenty-four were excluded for the following reasons: 12 
investigations (2 included patients with organ transplants) 
involved <3 cases; 5 had <3 cases linked by genotype and 
epidemiology; 5 were international investigations; and 2 
had insufﬁ  cient data in CDC reports.
Patient Summaries
The 27 outbreaks included in the review involved 
398 patients (median 10 patients/outbreak, range 3–35 
patients). Of these patients, 364 (91%) were US-born and 
50 (13%) were <15 years of age (Table 1). Three hundred 
thirty-three (84%) had pulmonary disease, including 204 
(61%) and 284 (85%) with smear-positive and culture-
positive TB, respectively. Eighty-nine percent of isolates 
(253 of 284) were susceptible to ﬁ  rst-line TB medications 
(Table 1). Of the 197 patients for whom the reason for 
initial TB evaluation was documented, 74 (38%) were 
evaluated because of TB symptoms, and 57 (30%) were 
detected as part of a contact investigation. Ninety-nine 
(25%) patients required hospitalization, and 23 (6%) died. 
Infectious periods were documented for 172 patients; the 
mean and median infectious periods were 6 and 5 months, 
respectively (range 1–56 months).
Most patients did not have established medical risk 
factors for TB (Table 2). Although the total number of 
patients tested for HIV was not available, HIV infection 
was documented for 45 patients (12%). Multiple social 
risk factors for TB were documented: 233 (58%) patients 
reported alcohol abuse or use of illicit drugs, 126 (32%) 
had a history of incarceration, and 78 (20%) had a history 
of homelessness. Sixteen (4%) patients were documented 
to have a previous diagnosis of TB; of these, 7 (44%) had 
received incomplete TB treatment.
Spoligotype and MIRU genotype data were available 
for 22 of 27 outbreaks. Three outbreaks involved a 
Beijing strain (spoligotype 000000000003771, MIRU 
223325173533); the remaining 19 had genotypes that 
differed from each other. The most frequent strain lineage 
in these outbreaks was EuroAmerican.
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Outbreak Summaries
US birth and substance abuse were predominant features 
of outbreaks (Table 3). On the basis of >50% of outbreak 
patients having a particular characteristic, the criterion 
used to ascribe a characteristic to an outbreak, 24 of the 
total 27 outbreaks were characterized by US-born persons, 
and 18 outbreaks by patients with reported substance 
abuse. Fourteen (52%) outbreaks were characterized by 
US-born men who used alcohol to excess or illicit drugs, 
i.e., marijuana, cocaine, methamphetamine, or heroin. All 
8 outbreaks characterized by patients with incarceration 
histories and the 4 characterized by homelessness had a 
predominance of patients with reported substance abuse.
Of the 24 outbreaks that occurred among predominantly 
US-born persons, 21 outbreaks involved substance abuse. 
For 17 (71%) outbreaks, >50% of patients reported substance 
abuse; for 2 additional outbreaks, >40% of patients reported 
substance abuse; and in 2 others, the source patients who 
reported substance abuse had prolonged infectious periods 
during which TB was transmitted. In all, 21 (87%) of 24 
outbreaks of predominantly US-born patients could thus 
be characterized as being related to substance abuse. The 
remaining 3 outbreaks associated with US-born persons 
were characterized by delayed diagnosis that resulted in 
transmission in a health care facility (6), among family 
members of a recently incarcerated patient (7), and among 
family members of an undocumented worker (17).
Three of the 27 outbreaks occurred among 
predominantly foreign-born persons. In 1 of these 
outbreaks, all patients engaged in substance abuse, and 
although these patients were foreign-born, they had been 
in the United States for more than a decade (18). The 
other 2 outbreaks among foreign-born persons involved 
transmission in school, church, and household settings. 
In each outbreak, the foreign-born patients did not access 
health care (caused by, in 1 outbreak, fear of repercussions 
for being undocumented, resulting in multidrug-resistant 
TB transmission among family members) (17).
Outbreak Contributing Factors and Hotspots
Table 4 describes the most common outbreak 
contributing factors, which for 24 outbreaks was prolonged 
infectiousness. In 4 outbreaks in which patients delayed 
seeking medical attention for their TB symptoms, in 7 
where provider-related diagnostic delays occurred, and in 
1 where both types of delay occurred, >40% of patients had 
reported substance abuse. Incomplete contact investigations 
because of limited resources or a hard-to-reach population 
contributed to 10 outbreaks.
Drug house was the most commonly identiﬁ  ed 
hotspot (17 outbreaks), followed by homeless shelter 
(n = 5), correctional facility (n = 4), household (n = 4), 
workplace (n = 4), church (n = 3), bar (n = 2), school (n = 
1), and automobile (n = 1). Ten of the 17 drug houses were 
primarily residences with extended family members, and 
the other 7 were largely venues where unrelated persons 
gathered strictly for the use of illicit substances. In the 4 
household outbreaks, crowded living conditions among 
extended families (primarily foreign-born in 2 outbreaks) 
were the main TB risk factors.
Interventions
The most frequently documented intervention to 
control the outbreak was to prioritize contacts based on 
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Table 1. Characteristics of patients in CDC–investigated TB 
outbreaks, United States, 2002–2008 
Characteristic No. (%) patients
Total 398 (100) 
Demographics 
 US-born 364  (91) 
 Black 265  (67) 
 Male  sex 259  (65) 
 White 66  (17) 
 Age  <15  y 50  (13) 
 Hispanic 31  (8) 
Clinical signs and outcomes 
 Pulmonary  TB  333  (84) 
    Cavity on chest radiograph  122 (37) 
    Sputum acid-fast bacilli smear positive  204 (61) 
    Sputum culture positive  284 (85)† 
    Susceptible to first-line tuberculosis  
   medications 
253 (89) 
 Hospitalization  99  (25) 
 Death  23  (6) 
*TB, tuberculosis; CDC, Centers for Disease Control and Prevention. 
†An additional 10 patients had non-sputum specimens that were culture-
positive. 
Table 2. Tuberculosis risk factors for patients in CDC–
investigated TB outbreaks, United States, 2002–2008* 
Risk factor†  No. (%) patients 
Total 398 (100) 
Medical
  HIV co-infection  46 (12)‡ 
 Diabetes  23  (6) 
  Immunosuppression (not HIV associated)  14 (4) 
  History of TB  16 (4) 
  Incomplete treatment  7 (44) 
Social 
  Any substance abuse  233 (58) 
  Alcohol abuse  204 (51) 
  Nonintravenous drug use  117 (29) 
  Intravenous drug use  19 (5) 
  Incarceration history§  126 (32) 
 Homelessness  78  (20) 
*TB, tuberculosis; CDC, Centers for Disease Control and Prevention. 
†As documented in CDC reports of onsite investigation with information 
generally gathered through patient chart reviews or interviews. 
‡Minimum estimate because complete data on the number of patients 
tested were not available. 
§Time frame before TB diagnosis not always documented in CDC reports. 
The National Tuberculosis Surveillance System collects data on 
incarceration at time of TB diagnosis. RESEARCH
risk for infection and progression to disease to ensure that 
the highest risk contacts were completely evaluated (14 
outbreaks). This intervention was necessitated by the large 
number of contacts identiﬁ  ed; contact investigation of 398 
patients had generated 16,559 contacts. Of these contacts, 
10,142 (61%) had been evaluated by the time of the onsite 
investigation; 2,128 (21%) were found to have latent TB 
infection (range 4%–65% per outbreak). Other frequently 
used interventions included educating community health 
care providers, e.g., emergency departments, to be vigilant 
for TB in patients seeking treatment at their facilities 
(13 outbreaks), and location-based screening, which 
involves offering TB screening to potential contacts at that 
particular outbreak’s hotspot or other convenient location 
(10 outbreaks).
Discussion
US-born persons who reported substance abuse most 
strongly characterized the TB outbreaks in this review: 24 of 
the 27 total outbreaks involved primarily US-born patients, 
and 19 of these outbreaks involved >40% of patients with 
reported drug or alcohol abuse. This predominance of 
substance abuse suggests that it remains one of the greatest 
challenges to controlling TB transmission in the United 
States.
Because this descriptive review of TB outbreaks in the 
United States was restricted to investigations that prompted 
public health jurisdictions to request CDC assistance, it 
might lack generalizability to all TB outbreaks in the United 
States. Outbreaks involving hard-to-reach populations, 
such as those involving substances abuse or homelessness, 
with a tendency to overwhelm local public health 
resources, might be overrepresented. On the other hand, 
social risk factors such as substance abuse that are based 
on self-reported behavior might have been underdisclosed 
because of associated social stigma. Data on key medical 
risk factors such as HIV and diabetes might have been 
pending or missing during an investigation and therefore 
not systematically included. Because genotyping might not 
have been conducted on every culture-positive case in the 
jurisdictions affected by these outbreaks, especially during 
the ﬁ  rst 2 years of this review, some cases could have been 
missed, underestimating the scope of these outbreaks. 
Despite these limitations, characteristics found to be 
associated with intense TB transmission are consistent with 
ﬁ  ndings in the previous literature.
Although the case rate is 10× higher among foreign-
born than among US-born persons, (21), this disparity was 
markedly lacking in our review; 91% of outbreak patients 
were US born. Prior studies have demonstrated that recent 
transmission occurs mainly among US-born persons, with 
foreign-born persons more likely to develop reactivation of 
latent TB infection acquired before immigration (24–26). 
Similar to other studies (25–27), our few examples of TB 
outbreaks among immigrants were all associated with 
crowded living conditions and lack of access to medical 
care, whereas outbreaks that involved mainly US-born 
persons were associated with substance abuse and other 
risk factors, such as homelessness and incarceration.
Among nationally reported TB cases, substance abuse 
has been estimated to be the most prevalent modiﬁ  able 
TB risk factor, reported by 29% of US-born vs. 8.3% 
of foreign-born patients (28). In our overview, 58% of 
outbreak patients self-reported substance abuse. Consistent 
with national TB surveillance regarding substance abuse, 
alcohol was the most commonly reported substance. 
Alcohol has been documented to increase the risk for TB 
exposure, susceptibility to infection, and progression to 
active disease (29,30). Contact investigations among bar 
patrons have yielded latent TB infection rates of 40%–
50% (29,31), highlighting the transmission risks in this 
population. Failure by contacts who abuse alcohol to be 
treated for latent TB infection can prolong outbreaks if 
active TB subsequently develops in these persons and they 
then serve as additional sources of transmission (4).
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Table 3. Predominant characteristics of CDC–investigated TB 
outbreaks, United States, 2002–2008* 
Characteristic No. (%) outbreaks†  
Total 27 (100) 
US born  24 (89) 
Male sex  22 (81) 
Substance abuse (alcohol/drugs)  18 (67) 
Acid-fast bacilli smear positive  17 (63) 
Non-Hispanic black  16 (59) 
Incarceration history  8 (30) 
Cavitary disease on chest radiograph  7 (26) 
Non-Hispanic white  4 (15) 
Homelessness 4 (15) 
Hispanic 3 (11) 
HIV co-infection  1 (4) 
*TB, tuberculosis; CDC, Centers for Disease Control and Prevention. 
†Outbreak had >50% of patients with the select characteristic. 
Table 4. Factors contributing to 27 CDC–investigated TB
outbreaks, United States, 2002–2008*
Factor No. outbreaks†
Prolonged infectious period 24
Provider related
Delayed diagnosis 12
Inappropriate treatment 2
Patient related
Delayed diagnosis because of late 
access to care
6
Nonadherence with treatment 5
Mistrust or fear of public health system 6
Incomplete contact investigation 10
Crowded setting with high-risk population 7
*TB, tuberculosis; CDC, Centers for Disease Control and Prevention.
†Categories not mutually exclusive.  Tuberculosis Outbreak Investigations
Substance abuse is a long-established risk factor for 
TB infection and disease (32,33), but in recent years its 
role in fueling TB transmission has also been recognized 
(10–12,14,15,18,19,28,29,31,32). Persons who report 
substance abuse are associated with increased TB 
transmission because of sociobehavioral and clinical TB 
risk factors. First, persons who report substance abuse are 
more likely to have smear-positive disease and experience 
treatment failure (28,34), e.g, because of nonadherence, 
both of which can increase infectiousness (20). The higher 
prevalence of smear positivity might be attributed to delayed 
diagnosis, or, in cases of crack cocaine use, pulmonary 
damage that leads to alveolar macrophage impairment and 
cytokine dysfunction (34). Second, persons who report 
substance abuse are likely to experience a prolonged 
infectious period because of delays in seeking medical 
care and, once they are medically evaluated, receiving a 
TB diagnosis (18,31,32). Third, sharing of drugs or alcohol 
often occurs in conﬁ  ned and poorly ventilated settings such 
as drug houses (4,10–12,15,18,19), bars (15,29,31), homes 
(7,10), and vehicles (18)—all of which facilitate close 
and prolonged contact. The most common hotspots in this 
review were settings in which drug use occurred; poverty, 
unstable housing, and overcrowded conditions exacerbated 
TB transmission (4,7–9,11,15,18,19). Fourth, contacts of 
TB patients are often difﬁ  cult to identify because patients 
want to protect the names of contacts with whom they 
engage in illicit or other activities perceived to have social 
stigma (10,28,31,32). Our ﬁ  nding of an overall 21% latent 
TB infection rate among contacts, lower than the expected 
30% (20), might reﬂ   ect evaluation of relatively lower 
risk contacts whose names were easier to elicit. Finally, 
contacts with substance abuse can be difﬁ  cult to locate, 
be less likely to accept and adhere to treatment, and have 
a greater risk for adverse reactions from medication, e.g., 
related to interaction of alcohol with isoniazid (28,29,32).
Given the predominance of patients with substance 
abuse in our review, it is not surprising that prolonged 
infectious period was the most common outbreak 
contributing factor. Delayed diagnosis was the most 
common cause (14/27 outbreaks) and has been cited 
as a major contributor to TB outbreaks (3,7,11–15,
22,23,25,27,35,36). In 1 outbreak, during a 1-year 
infectious period, the source patient lived in 4 locations, all 
crowded settings, and shared illicit drugs with household 
members, facilitating TB transmission to 3 adults and 3 
children (11). In another outbreak, during the 9 months 
that the source patient’s diagnosis was delayed, the patient 
was in and out of jail and had multiple moves to new 
residences, resulting in 37 additional cases (including 10 
children) across 3 counties (9). These examples of intense 
transmission occurring before a correct diagnosis was made 
highlight the need for educating health care providers to 
suspect TB when encountering either persons born abroad 
or domestically with social risk factors for TB, such as 
substance abuse, homelessness, and incarceration history 
(6,7,9,11,12,15,35). Failure to do so can lead to outbreaks 
that overwhelm public health resources. Additionally, 
raising general awareness about TB so that patients seek 
early medical care and know the value of completing 
treatment are critical to ending transmission (22,36).
This review found that incomplete contact investigation 
was the second most common contributing factor to TB 
outbreaks. When contact investigations are incomplete, 
a pool of latent TB infection remains, threatening to 
generate additional cases and cause ongoing transmission 
(10,15,24). Compounding these risks, persons who report 
substance abuse are more likely to be poor, homeless, and 
have an incarceration history—all documented TB risk 
factors (5,11,13–15,28,37,38). When contact investigations 
involve a hard-to-reach population, conventional methods 
of contact tracing may need to be expanded to include other 
approaches (2,5,10,13–15,27,39). To optimize the yield of 
contact investigation, the 2 interventions most frequently 
used in these outbreaks were prioritizing screening of 
contacts on the basis of TB risk (3,5,6,8–11,18) and 
offering location-based TB screening at speciﬁ  c venues 
associated with each outbreak, including bars, shelters, 
and drug houses (5,6,10,13,14). Although this intervention 
is resource-intensive, its beneﬁ  ts have been recognized in 
several investigations involving hard-to-reach populations 
(10,14,31). In 1 outbreak, unnamed contacts encountered 
at a drug house frequented by numerous TB patients were 
offered screening and were found to be 8× more likely to 
have a positive tuberculin skin test result than were named 
contacts (10).
Although this review was limited to outbreaks in 
which CDC was invited to assist and might not represent 
all TB outbreaks in the United States, it provides an 
opportunity to identify common themes among outbreaks 
which, when present, tend to challenge local public health 
capacity. These outbreaks featured US birth and substance 
abuse—factors shown to be independently associated with 
genotype clustering, a marker for recent TB transmission 
(39,40). Although TB incidence has been decreasing in the 
United States, its elimination will not be achieved without 
more effective strategies to prevent, detect, and treat TB 
among persons who are known to abuse substances.
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